Copper Absorption Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Copper Absorption Inhibitor
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gland Pharma Ltd | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 216249-002 | May 3, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Nivagen Pharms Inc | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 214597-001 | Jul 5, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Am Regent | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 209377-002 | Jul 18, 2019 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Nivagen Pharms Inc | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 214597-002 | Jul 5, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |